COVID vaccines may improve immunotherapy effects, and a drug combination reduces the risk for death in bladder cancer.

by Darlene Dobkowski

Prior authorizations pose a significant time burden for patients, and sentinel lymph node biopsy reduces side effects in cervical cancer.

by Marci A. Landsmann

Older people with multiple myeloma can receive a less toxic drug regimen, and the FDA approves an immunotherapy for people with high-risk skin cancer.

by Thomas Celona

Widespread uptake of HPV vaccine linked to reduced rates of cancer-causing infection in all, and radiation prevents recurrence in locally advanced bladder cancer.

by Eric Fitzsimmons

Multiple myeloma survivor Jonathan Gluck reflects on uncertainty, and the scientific progress that has kept him living with cancer for more than two decades.

by Eric Fitzsimmons

US trial to look at impact of AI-assisted mammograms, and vitamin B12 may help curb chemotherapy-associated hand-foot syndrome.

by Darlene Dobkowski

Opening session from AACR conference highlights how perseverance and adversity have informed cancer disparities research over the years.

by Eric Fitzsimmons

Report highlights progress against cancer amid call for federal government to fund cancer research, and low-dose aspirin fends off recurrence after surgery in colorectal cancer.

by Marci A. Landsmann

Despite research linking fruits and vegetables to cancer survival, many people do not change their eating habits after diagnosis.

by Darlene Dobkowski

Combination of targeted therapy and chemotherapy prolongs survival in lung cancer, and FDA approves a chemotherapy-releasing device to treat bladder cancer.

by Thomas Celona